Anti-NLRP3 antibody [RM1021]
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(9 Publications)
Anti-NLRP3 antibody [RM1021] (ab283819) is a rabbit recombinant multiclonal antibody detecting NLRP3 in Western Blot, Flow Cytometry (Intra), IP, ICC/IF. Suitable for Human, Mouse, Rat.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
View Alternative Names
C1orf7, CIAS1, NALP3, PYPAF1, NLRP3, Angiotensin/vasopressin receptor AII/AVP-like, Caterpiller protein 1.1, Cold-induced autoinflammatory syndrome 1 protein, Cryopyrin, PYRIN-containing APAF1-like protein 1, CLR1.1, Cias1, Mmig1, Nalp3, Pypaf1, Nlrp3, Cold autoinflammatory syndrome 1 protein homolog, Cryopyrin, Mast cell maturation-associated-inducible protein 1, PYRIN-containing APAF1-like protein 1
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-NLRP3 antibody [RM1021] (AB283819)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized THP-1 (human monocytic leukemia monocyte) cells labelling NLRP3 with ab283819 at 1/50 (11.4 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 2ug/ml dilution (Green). Confocal image showing increased mainly cytoplasmic staining in THP-1 cells treated with 12-O-Tetradecanoylphorbol-13-acetate (80 nM) for 16 h then replaced it with lipopolysaccharide (1 ug/ml) for 8 h. ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 2.5ug/ml dilution (Red). The Nuclear counterstain was DAPI (Blue). Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 2ug/ml dilution.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-NLRP3 antibody [RM1021] (AB283819)
Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized THP-1 (Human monocytic leukemia monocyte) treated with 50nM PMA and 5ug/ml LPS for 24h(Red) / Untreated control (Green) cells labelling NLRP3 with ab283819 at 1/50 dilution (1ug) (Red) and Green (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/2000 dilution was used as the secondary antibody.
- IP
Supplier Data
Immunoprecipitation - Anti-NLRP3 antibody [RM1021] (AB283819)
NLRP3 was immunoprecipitated from 0.35 mg THP-1 (Human monocytic leukemia monocyte) whole cell lysate 10ug with ab283819 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab283819 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution. Lane 1 : THP-1 (Human monocytic leukemia monocyte) whole cell lysate Lane 2 : ab283819 IP in THP-1 (Human monocytic leukemia monocyte) whole cell lysate Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab283819 in THP-1 whole cell lysate Blocking and dilution buffer and concentration : 5% NFDM/TBST. Lower bands should be cleavage fragment of NLRP3. (PMID : 26119741)
All lanes:
Immunoprecipitation - Anti-NLRP3 antibody [RM1021] (ab283819) at 1/30 dilution
Lane 1:
THP-1 (Human monocytic leukemia monocyte) whole cell lysate
Lane 2:
ab283819 IP in THP-1 (Human monocytic leukemia monocyte) whole cell lysate
Secondary
All lanes:
Immunoprecipitation - Anti-NLRP3 antibody [RM1021] (ab283819) at 1/5000 dilution
false
Exposure time: 84s
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-NLRP3 antibody [RM1021] (AB283819)
Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) treated with 10ug/ml LPS for 8h(Red) / Untreated control (Green) cells labelling NLRP3 with ab283819 at 1/500 dilution (0.1ug) (Red) and Green (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/2000 dilution was used as the secondary antibody.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-NLRP3 antibody [RM1021] (AB283819)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized RAW 264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) cells labelling NLRP3 with ab283819 at 1/50 (11.4 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 2ug/ml dilution (Green). Confocal image showing increased cytoplasmic staining in RAW 264.7 cells treated with lipopolysaccharide (10 ug/ml) for 8 h. ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 2.5ug/ml dilution (Red). The Nuclear counterstain was DAPI (Blue). Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 2ug/ml dilution.
- IP
Supplier Data
Immunoprecipitation - Anti-NLRP3 antibody [RM1021] (AB283819)
NLRP3 was immunoprecipitated from 0.35 mg RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate 10ug with ab283819 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab283819 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution. Lane 1 : RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate 10 µg Lane 2 : ab283819 IP in RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab283819 in RAW 264.7 whole cell lysate Blocking and dilution buffer and concentration : 5% NFDM/TBST. Lower bands should be cleavage fragment of NLRP3. (PMID : 26119741)
All lanes:
Immunoprecipitation - Anti-NLRP3 antibody [RM1021] (ab283819) at 1/30 dilution
All lanes:
RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate
Secondary
All lanes:
Immunoprecipitation - Anti-NLRP3 antibody [RM1021] (ab283819) at 1/5000 dilution
false
Exposure time: 84s
- WB
Supplier Data
Western blot - Anti-NLRP3 antibody [RM1021] (AB283819)
Blocking and diluting buffer and concentration : Intercept® (TBS) Blocking Buffer diluted with an equal volume of TBS Lysates at 20 µg per lane. The samples were run on a Bis-Tris gel under reducing conditions. Western blot : Anti-NLRP3 antibody (ab283819) staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody 6C5 (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab283819 was shown to bind specifically to NLRP3. Target of interest was observed at 118 kDa in untreated wild-type THP-1 cell lysates (lane 1) with no signal observed at this size in NLRP3 knockout cell line ab280063 (knockout cell lysate ab280122) (lane 2). To generate this image, samples were first run on an SDS-PAGE gel then transferred onto an immobilon-FL PVDF membrane. Membranes were blocked in a fluorescent western blot (TBS-based) blocking solution before incubation with primary antibodies overnight at 4 °C. Blots were washed in TBS-T, incubated with secondary antibodies Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution for 1 h at room temperature, washed again then imaged.
All lanes:
Western blot - Anti-NLRP3 antibody [RM1021] (ab283819) at 1/1000 dilution
Lane 1:
Wild-type THP-1 (Human monocytic leukemia monocyte) whole cell lysate at 20 µg
Lane 2:
NLRP3 knockout THP-1 whole cell lysate at 20 µg
Secondary
Lanes 1 - 2:
Goat Anti-Rabbit IgG H&L (800CW) at 1/20000 dilution
Lanes 1 - 2:
Goat anti-Mouse IgG H&L (680RD) at 1/20000 dilution
Observed band size: 118 kDa,37 kDa
false
- WB
Supplier Data
Western blot - Anti-NLRP3 antibody [RM1021] (AB283819)
Blocking and diluting buffer and concentration : 5% NFDM/TBST Negative control : Jurkat (PMID : 19767079). Exposure time : Lane1-3 : 3min; Lane4-5 : 37 seconds; Lane6-7 : 10 seconds
All lanes:
Western blot - Anti-NLRP3 antibody [RM1021] (ab283819) at 1/1000 dilution
Lane 1:
Jurkat (Human T cell leukemia T lymphocyte) whole cell lysate at 20 µg
Lane 2:
THP-1 (Human monocytic leukemia monocyte) whole cell lysate at 20 µg
Lane 3:
THP-1 treated with 80nM TPA overnight, then 1μg/ml lipopolysaccharide (LPS) for 8h whole cell lysate at 20 µg
Lane 4:
RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate at 20 µg
Lane 5:
RAW 264.7 treated with 1μg/ml lipopolysaccharide (LPS) for 6h whole cell lysate at 20 µg
Lane 6:
NR8383 (Rat lu macrophage (alveolar)) whole cell lysate at 20 µg
Lane 7:
NR8383 treated with 1μg/ml lipopolysaccharide (LPS) for 4h, then add 1μg/ml BFA for another 3h whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 118 kDa
false
- WB
Lab
Western blot - Anti-NLRP3 antibody [RM1021] (AB283819)
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/1000000 dilution.
After extending the induction period to 16 hours, prolonged LPS stimulation may trigger cellular feedback regulation (PMID : 26412089), resulting in less pronounced induction effects. It is recommended to test varying time and concentration gradients to optimize induction.
All lanes:
Western blot - Anti-NLRP3 antibody [RM1021] (ab283819) at 1/1000 dilution
Lanes 1, 3, 5 and 7:
RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate at 20 µg
Lane 2:
RAW 264.7 treated with 100ng/ml lipopolysaccharide (LPS) for 2h whole cell lysate at 20 µg
Lane 4:
RAW 264.7 treated with 100ng/ml lipopolysaccharide (LPS) for 6h whole cell lysate at 20 µg
Lane 6:
RAW 264.7 treated with 100ng/ml lipopolysaccharide (LPS) for 16h whole cell lysate at 20 µg
Lane 8:
RAW 264.7 treated with 100ng/ml lipopolysaccharide (LPS) for 24h whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 118 kDa
false
Exposure time: 3s
Related conjugates and formulations (1)
-
Anti-NLRP3 antibody [RM1021] - BSA and Azide free
Reactivity data
Product details
What is this antibody validated in?
Anti-NLRP3 antibody [RM1021] (ab283819) is a rabbit recombinant recombinant multiclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunocytochemistry/immunofluorescence (ICC/IF) in Human, Mouse, Rat samples.
What is the molecular weight of NLRP3?
Anti-NLRP3 [RM1021] (ab283819) specifically detects a band for NLRP3 (UniProt: Q96P20) at a molecular weight of 118kDa.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Specificity confirmed
The specificity of Anti-NLRP3 antibody [RM1021] (ab283819) has been confirmed by Western blot testing in NLRP3 Knockout THP-1 cell line, ab280063.
Other related products
We have a range of other formats of antibody clone [RM1021] also available for your convenience: ab283819, Carrier free - ab314905
What are recombinant multiclonals?
Recombinant multiclonals are a mixture of recombinant antibodies co-expressed from a library of heavy and light chains. They offer several advantages including:
- - The sensitivity of polyclonal antibodies by recognising multiple epitopes
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
View our range of recombinant multiclonal antibodies.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
NLRP3 is central to the body's defense mechanism by participating in forming the inflammasome complex which activates caspase-1. This activation leads to the cleavage of pro-inflammatory cytokines like IL-1Β and IL-18 into their active forms. NLRP3's function is essential for mounting an effective immune response to infections and damage signals. It senses a range of stimuli including crystalline substances and cellular stress triggering an immune response. Its expression is tightly regulated to prevent excessive inflammation.
Pathways
The NLRP3 inflammasome is key in the innate immune response and inflammation pathways. It links cellular stress signals to inflammation through the activation of caspase-1 which is important for the IL-1 signaling pathway. NLRP3 interacts with other proteins like ASC (apoptosis-associated speck-like protein containing a CARD) to form the inflammasome complex which is a core part of the inflammatory signaling pathways and links innate and adaptive immunity.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (9)
Recent publications for all applications. Explore the full list and refine your search
Cell biology and toxicology 41:131 PubMed40986115
2025
Applications
Unspecified application
Species
Unspecified reactive species
Animals : an open access journal from MDPI 15: PubMed40723465
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of microbiology and biotechnology 35:e2501052 PubMed40659556
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 32: PubMed40417884
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:16341 PubMed40348802
2025
Applications
Unspecified application
Species
Unspecified reactive species
American journal of reproductive immunology (New York, N.Y. : 1989) 93:e70084 PubMed40349356
2025
Applications
Unspecified application
Species
Unspecified reactive species
BMC cardiovascular disorders 25:176 PubMed40082765
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of pain research 18:1115-1129 PubMed40070891
2025
Applications
Unspecified application
Species
Unspecified reactive species
Biotechnology and applied biochemistry 72:460-468 PubMed39358914
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com